FDA approves prescription eye drops that improve near vision – CBS New York


NEW YORK (CBSNew York) – The FDA recently approved prescription eye drops to improve near vision.

As CBS2’s Dr Max Gomez reported on Thursday, it could be a life-changing drug because most people are certain to have blurry, close-up vision after their mid-forties.

READ MORE: As COVID cases climb in tri-state region, Pfizer says its vaccine booster appears to protect against Omicron variant

Toni Wright leads a double life on her farm in western Pennsylvania – partly controlling her chickens or cows and working from home as an online retail consultant.

“I have readers everywhere,” Wright said.

It’s the only way Wright, 54, can read it up close.

“I was in denial because for me it was a sign of aging,” Wright said.

In 2019, Wright’s doctor told him about eye drops that could temporarily correct his near vision.

“I wouldn’t need my readers as much, especially on the computer, where I would always need them,” Wright said.

READ MORE: COVID-19 update: Researchers say Omicron variant could quickly overtake Delta variant in cases across the United States

Wright was one of 750 participants in a clinical trial to test the drug Vuity, the first eye drops approved by the FDA to treat age-related blurry and near vision, also known as presbyopia.

“Vuity uses the eye’s natural ability to reduce the size of its pupil,” said Dr. George Waring, principal investigator of the trial. “Reducing the pupil size increases the depth of field or depth of field, allowing you to naturally focus on different areas. “

One drop in each eye provides sharper vision for six to 10 hours.

A Vuity spokesperson said the drug would cost around $ 80 for a 30-day supply. It works best in people between the ages of 40 and 55. Side effects from the three-month trial included headaches and red eyes.

“It’s definitely a life changing… just a convenience of having that option of putting the drops on and being able to go,” Wright said.

Prescription drops are intended for mild to intermediate cases and are less effective after age 65.

NO MORE NEWS: Pediatric COVID cases rise as parents rush to immunize children ahead of holiday season

The manufacturer cautions against using the drops when driving at night or performing activities in low light conditions, as the narrowed pupil reduces the amount of light entering the eye.

Source link


Comments are closed.